C-peptide prevents glomerular hypertrophy and mesangial matrix expansion in diabetic rats

Abstract

C-peptide administration in replacement dose to streptozotocin-diabetic rats serves to limit or prevent the glomerular hypertrophy and the mesangial matrix expansion seen in the post-hyperfiltration phase of early diabetic nephropathy.